EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas

High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMP...

Full description

Bibliographic Details
Main Authors: Tsai, Wen-Chiuan, Chen, Ying, Huang, Li-Chun, Lee, Herng-Sheng, Ma, Hsin-I, Huang, Shih-Ming, Sytwu, Huey-Kang, Hueng, Dueng-Yuan
Format: Online
Language:English
Published: Springer US 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744650/
id pubmed-3744650
recordtype oai_dc
spelling pubmed-37446502013-08-16 EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas Tsai, Wen-Chiuan Chen, Ying Huang, Li-Chun Lee, Herng-Sheng Ma, Hsin-I Huang, Shih-Ming Sytwu, Huey-Kang Hueng, Dueng-Yuan Laboratory Investigation High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMPRIN. Analyzing the public delinked database from the Gene Expression Omnibus profile, the results showed that the EMMPRIN mRNA level was higher in WHO grade IV (n = 81) than in grade III (n = 19, p < 0.0005) astrocytomas and non-tumor brain tissue controls (n = 23, p < 0.00001). The results of tissue microarray-based immunohistochemical (IHC) staining revealed that EMMPRIN levels positively correlated with WHO grades for astrocytomas (p = 0.008) and meningiomas (p = 0.048). EMMPRIN mRNA levels in conventional glioma cell lines (n = 36) was not less than those in glioma primary culture cells (n = 27) and glioblastoma stem-like cells (n = 12). The GBM8401, U87MG, and LN229 human glioma cell lines also overexpressed EMMPRIN. Hematoxylin and eosin, IHC, and immunofluorescence staining of xenografts confirmed that high-grade brain tumors overexpressed EMMPRIN. Lastly, Kaplan–Meier analysis revealed poorer survival in WHO grade IV (n = 56) than in grade III astrocytomas (n = 21, by log-rank test; p = 0.0001, 95 % CI: 1.842–3.053). However, in high-grade astrocytomas, there was no difference in survival between high and low EMMPRIN mRNA levels. Thus, this study identified that high-grade brain tumors overexpress EMMPRIN, which positively correlates with WHO grades in human astrocytomas and meningiomas, and suggests that EMMPRIN may be a therapeutic target of brain tumor. Springer US 2013-07-02 2013 /pmc/articles/PMC3744650/ /pubmed/23817808 http://dx.doi.org/10.1007/s11060-013-1184-5 Text en © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Tsai, Wen-Chiuan
Chen, Ying
Huang, Li-Chun
Lee, Herng-Sheng
Ma, Hsin-I
Huang, Shih-Ming
Sytwu, Huey-Kang
Hueng, Dueng-Yuan
spellingShingle Tsai, Wen-Chiuan
Chen, Ying
Huang, Li-Chun
Lee, Herng-Sheng
Ma, Hsin-I
Huang, Shih-Ming
Sytwu, Huey-Kang
Hueng, Dueng-Yuan
EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
author_facet Tsai, Wen-Chiuan
Chen, Ying
Huang, Li-Chun
Lee, Herng-Sheng
Ma, Hsin-I
Huang, Shih-Ming
Sytwu, Huey-Kang
Hueng, Dueng-Yuan
author_sort Tsai, Wen-Chiuan
title EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
title_short EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
title_full EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
title_fullStr EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
title_full_unstemmed EMMPRIN expression positively correlates with WHO grades of astrocytomas and meningiomas
title_sort emmprin expression positively correlates with who grades of astrocytomas and meningiomas
description High-grade primary brain tumors possessed poor outcome due to invasiveness. Extracellular matrix metalloproteinase inducer (EMMPRIN) stimulates peri-tumoral fibroblasts to secrete matrix metalloproteinase and promote invasiveness. This study hypothesized that high-grade brain tumors overexpress EMMPRIN. Analyzing the public delinked database from the Gene Expression Omnibus profile, the results showed that the EMMPRIN mRNA level was higher in WHO grade IV (n = 81) than in grade III (n = 19, p < 0.0005) astrocytomas and non-tumor brain tissue controls (n = 23, p < 0.00001). The results of tissue microarray-based immunohistochemical (IHC) staining revealed that EMMPRIN levels positively correlated with WHO grades for astrocytomas (p = 0.008) and meningiomas (p = 0.048). EMMPRIN mRNA levels in conventional glioma cell lines (n = 36) was not less than those in glioma primary culture cells (n = 27) and glioblastoma stem-like cells (n = 12). The GBM8401, U87MG, and LN229 human glioma cell lines also overexpressed EMMPRIN. Hematoxylin and eosin, IHC, and immunofluorescence staining of xenografts confirmed that high-grade brain tumors overexpressed EMMPRIN. Lastly, Kaplan–Meier analysis revealed poorer survival in WHO grade IV (n = 56) than in grade III astrocytomas (n = 21, by log-rank test; p = 0.0001, 95 % CI: 1.842–3.053). However, in high-grade astrocytomas, there was no difference in survival between high and low EMMPRIN mRNA levels. Thus, this study identified that high-grade brain tumors overexpress EMMPRIN, which positively correlates with WHO grades in human astrocytomas and meningiomas, and suggests that EMMPRIN may be a therapeutic target of brain tumor.
publisher Springer US
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744650/
_version_ 1612003417358598144